Suppr超能文献

肠膜明串珠菌葡聚糖蔗糖酶的生物工程化,赋予了葡聚糖合成和/或受体产物合成的特定键形成。

Bioengineering of Leuconostoc mesenteroides glucansucrases that gives selected bond formation for glucan synthesis and/or acceptor-product synthesis.

机构信息

Research Institute for Catalysis and School of Biological Sciences and Technology, Chonnam National University, Gwang-Ju, Korea.

出版信息

J Agric Food Chem. 2011 Apr 27;59(8):4148-55. doi: 10.1021/jf104629g. Epub 2011 Mar 10.

Abstract

The variations in glucosidic linkage specificity observed in products of different glucansucrases appear to be based on relatively small differences in amino acid sequences in their sugar-binding acceptor subsites. Various amino acid mutations near active sites of DSRBCB4 dextransucrase from Leuconostoc mesenteroides B-1299CB4 were constructed. A triple amino acid mutation (S642N/E643N/V644S) immediately next to the catalytic D641 (putative transition state stabilizing residue) converted DSRBCB4 enzyme from the synthesis of mainly α-(1→6) dextran to the synthesis of α-(1→6) glucan containing branches of α-(1→3) and α-(1→4) glucosidic linkages. The subsequent introduction of mutation V532P/V535I, located next to the catalytic D530 (nucleophile), resulted in the synthesis of an α-glucan containing increased branched α-(1→4) glucosidic linkages (approximately 11%). The results indicate that mutagenesis can guide glucansucrase toward the synthesis of various oligosaccharides or novel polysaccharides with completely altered linkages without compromising high transglycosylation activity and efficiency.

摘要

不同葡聚糖蔗糖酶产物中糖苷键特异性的变化似乎基于其糖结合受体亚基中氨基酸序列的相对较小差异。来自肠膜明串珠菌 B-1299CB4 的 DSRBCB4 葡聚糖蔗糖酶的活性位点附近的各种氨基酸突变被构建。紧邻催化 D641(假定的过渡态稳定残基)的三个氨基酸突变(S642N/E643N/V644S)将 DSRBCB4 酶从主要合成α-(1→6)葡聚糖转变为合成含有α-(1→3)和α-(1→4)糖苷键分支的α-(1→6)葡聚糖。随后引入位于催化 D530(亲核试剂)旁边的突变 V532P/V535I,导致合成含有增加的分支α-(1→4)糖苷键的α-葡聚糖(约 11%)。结果表明,诱变可以引导葡聚糖蔗糖酶朝着合成各种寡糖或具有完全改变键的新型多糖的方向发展,而不会降低高转糖苷活性和效率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验